Interaction between endothelin and nitric oxide in sympathetic nerve modulation in hypertensive rats

Hypertension Research

Volumn 20, Issue 1, 1997, Pages 35-42

  Kumagai, Hiroo ^a   Suzuki, Hiromichi ^b   Ichikawa, Masashi ^a   Nishizawa, Masahiko ^a   Oshima, Naoki ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor antagonist; Endothelin type A receptor antagonist; Endothelin type B receptor antagonist; Nitric oxide; Renal sympathetic nerve activity

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; LOSARTAN; N(G) METHYLARGININE; NITRIC OXIDE; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HEART RATE; HYPERTENSION; KIDNEY; MALE; MEAN ARTERIAL PRESSURE; MODULATION; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

EID: 0030944840     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.35     Document Type: Article

References (29)

1. Kumagai H, Suzuki H, Ryuzaki M, Matsukawa S, Saruta H: Baroreflex control of renal sympathetic nerve activity is potentiated at early phase of two-kidney, one clip Goldblatt hypertension in conscious rabbits. Circ Res 1990; 67: 1309-1322.
2. Kumagai H, Suzuki H, Matsumura Y, Ryuzaki M, Saruta T: Differential effects of captopril and nicardipine on baroreflex control of sympathetic nerve activity and heart rate in renal hypertension. J Hypertens 1992; 10: 1485-1491.
3. Kumagai H, Suzuki H, Ichikawa M, et al: Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits. Circ Res 1993; 72: 1255-1265.
4. Shapoval LN, Sagach VF, Pobegailo LS: Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991; 132: 47-50.
5. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992; 70: 607-611.
6. Kuwaki T, Cao WH, Yamamoto M, Terui N, Kumada M: Cardiorespiratory effects of topical application of endothelin-1 to the ventral surface of the rat medulla. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): S343-S345.
7. Cao WH, Kuwaki T, Unekawa M, Ling GY, Terui N, Kumada M: Action of endothelin-1 on vasomotor neurons in rat rostral ventrolateral medulla. J Cardiovasc Pharmacol 1993; 22 (Suppl 8): S196-S198.
8. Kumagai H, Averill DB, Khosla MC, Ferrario CM: Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension 1993; 21: 476-484.
9. Kumagai H, Suzuki H, Ichikawa M, Nishizawa M, Saruta T: Renal sympathetic nerve activity of normotensive and hypertensive rats is differently mod-ulated by endothelial factors. Hypertension 1994; 24: 410 (Abstract).
10. Hirata Y, Emori T, Eguchi S, et al: Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993; 91: 1367-1373.
11. Boulanger C, Luscher TF: Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590.
12. Luscher TF, Dohi Y: Endothelium-derived relaxing factor and endothelin in hypertension. News Physiol Sci 1992; 47: 120-123.
13. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-1474.
14. Auch-Schwelk W, Katusic ZS, Vanhoutte PM: Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension 1992; 19: 442-445.
15. W-nitro-L-arginine methyl on pressor responses elicited by sympathetic nerve stimulation in pithed normotensive and hypertensive rats. Life Sci 1991; 49: 1989-1995.
16. Arnal J-F, Battle T, Menard J, Michel J-B: The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spon-taneously hypertensive rat. J Hypertens 1993; 11: 945-950.
17. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R: L-arginine-induced hypotension. Lancet 1990; 336: 696.
18. Lerman A, Sandok EK, Hildebrand FL Jr, Burnett JC Jr: Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 1992; 85: 1894-1898.
19. Ihara M, Noguchi K, Saeki T, et al: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992; 50: 247-255.
20. Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M: A novel endothelin ET A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biopliys Res Commun 1993; 195: 969-975.
21. Ishikawa K, Ihara M, Noguchi K, et al: Biochemical and pharmacological profile of a potent and selective endothelin B receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994; 91: 4892-4896.
22. Kumagai H, Averill DB, Ferrario CM: Renal nerve activity in rats with spontaneous hypertension: effect of converting enzyme inhibitor. Am J Physiol 1992; 263 (Regulatory Integrative Comp Physiol 32): R109-R115.
23. Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S: Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990; 15: 486-492.
24. Bains JS, Ferguson AV: Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor. Regul Pept 1994; 50: 53-59.
25. Matsuda T, Chapleau MW, Bates JN, Lewis SJ, Abboud FM: Endogenous nitric oxide suppresses baroreceptor activity by a cGMP independent mechanism. Circulation 1992; 86 (Suppl I): I-482. (Abstract)
26. Sigmon DH, Newman JM, Beierwaltes WH: Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats. J Am Soc Nephrol 1994; 4: 1675-1682.
27. Takahashi H, Nishimura M, Nakanishi T, et al: Effects of intracerebroventricular and intravenous injections of endothelin-1 on blood pressure and sympathetic activity in urethane-anesthetized rats. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): S287-S289.
28. Dohi Y, Luscher TF: Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction. Hypertension 1991; 18: 543-549.
29. Schini VB, Kim ND, Vanhoutte PM: The basal and stimulated release of EDRF inhibits the contractions evoked by endothelin-1 and endothelin-3 in aortae of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): S267-S271.